RHAPSIDO FDA approval date

The FDA approved RHAPSIDO on 30 Sep 2025.

FDA approval date
30 Sep 2025

Drug identity has not yet been verified against registry records

Also recorded as REMIBRUTINIB

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2025-09-30DayRHAPSIDOFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA218436", "applicant_as_listed_by_fda": "NOVARTIS", "brand_names": ["RHAPSIDO"], "active_ingredients": ["REMIBRUTINIB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20250930", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026